Cantor


Holiday Sales Provide Insight into Amazon.com, Inc. (AMZN) Ahead of 4Q Earnings: Top Analyst

Top analyst Youssef Squali at Cantor is anticipating a robust fourth quarter for Amazon.com, Inc.

Cantor Cheers As Jazz Pharmaceuticals plc Shares Rise 9%

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock is on a 9% rise after receiving abbreviated new drug application (ANDA) approval as well …

Cantor Wary on Alcobra Ltd Following Phase III Trial Failure

Alcobra Ltd (NASDAQ:ADHD) disappointed investors today with the news that its MEASURE trial failed to meet its primary endpoint based on investigator assessment …

Cantor Bullish on Celgene Corporation (CELG) After Raising Guidance; Sees 36% Upside

Cantor analyst Mara GoldsteinĀ came out today with a bullish note on shares of Celgene Corporation (NASDAQ:CELG), after the pharma giant pre-announced 2016 results …

Cantor Analyst Chimes In on Amarin Corporation plc (ADR) (AMRN) Following Corporate Update

In a research report published Tuesday, Cantor analyst Chiara Russo reiterated an Overweight rating on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), with …

AMAG Pharmaceuticals, Inc. (AMAG): Makena Autoinjector Key to Stock Performance in 2017

Cantor analyst William Tanner remains sidelined on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) amid their nearly 36% crash yesterday.

Cantor Offers Bullish Take on Gartner Inc (IT) Following Acquisition of CEB

Gartner Inc (NYSE:IT) shares were stumbling 11% yesterday after the company’s announcement that it had acquired fellow Professional Services firm CEB. However, Cantor …

Here’s Why Agile Therapeutics Inc (AGRX) Shares Are Crashing 49% Today; Cantor Remains Bullish

Agile Therapeutics Inc (NASDAQ:AGRX) investors are in a scramble today after the firm released top-line data from its SECURE Phase 3 study of …

Here’s Why Cantor Bullish on Cidara Therapeutics Inc (CDTX); Shares Rise 7%

Cantor analyst Chiara Russo is sharing some positive perspective on Cidara Therapeutics Inc (NASDAQ:CDTX) after the firm announced this morning the enrollment is …

Cantor Sees CAPB Advantage for Paratek Pharmaceuticals Inc (PRTK) in Wake of Cempra Inc (CEMP) CRL Setback

Cantor analyst Chiara Russo is liking the odds for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) after Cempra Inc (NASDAQ:CEMP) received a Complete Response Letter (CRL) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts